Vivo Capital, LLC Crispr Therapeutics Ag Transaction History

Vivo Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$23.52 - $58.17 $2.32 Million - $5.73 Million	-98,511 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$16.95 - $23.48 $853,720 - $1.18 Million	-50,367 Reduced 33.83%	98,511 $2.31 Million
Q3 2017 Nov 13, 2017	BUY	$16.75 - $20.66 $2.49 Million - $3.08 Million	148,878	148,878 $2.66 Million

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.48B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.